What role should the UK play?

The UK is already playing a leading role through a new project led by NICE and NHSE&I, which is trialling a new model for researching and investing in new antibiotics.

The UK made antibiotic resistance a centrepiece of its agenda during its G7 Presidency and has a 5-year National Action Plan to tackle antimicrobial resistance. This sets out how Britain will achieve its new 20-year vision for a world in which antibiotic resistance is contained and controlled by 2040.

The plans contain the detail for how the UK will address the “market failure” in antibiotics, with the NHS testing a first-of-its-kind ‘subscription-style’ payment model that will help incentivise companies to research and develop new drugs needed to tackle resistant infections.

Two products are involved in the UK project but we need to start thinking now about what arrangements should be put in place for all new antibiotics that come after them.

But solving antibiotic resistance needs global leaders to develop and implement solutions around the world so that we can work #TogetherForAntibiotics.

What can patient groups do?

If you want to get involved in the ABPI’s #TogetherforAntibiotics campaign, there are lots of opportunities to collaborate.

We have partnered with patient groups and charities to co-create content highlighting the importance of antibiotics and if you’d like to work with us on creating your own bespoke imagery or videos, please get in touch with pressoffice@abpi.org.uk. 

You can also read more about the issue by downloading our key messages here